Trials / Sponsors / Wuhan Sian Medical Technology Co., Ltd
Wuhan Sian Medical Technology Co., Ltd
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Humanized CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malign Acute Lymphoblastic Leukemia, B Cell Lymphoma | Phase 1 | 2019-05-27 |
| Unknown | Anti-CD19 CAR-T Therapy Combine With HSCT to Treat MRD+ B-cell Malignancies Acute Lymphoblastic Leukemia, B Cell Lymphoma | Phase 1 / Phase 2 | 2016-05-01 |
| Unknown | Anti-CD19 CAR-T Therapy Bridging to HSCT for CD19+ B-Cell Malignancies Acute Lymphoblastic Leukemia, B Cell Lymphoma | Phase 1 / Phase 2 | 2016-04-15 |
| Unknown | CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies Acute Lymphoblastic Leukemia, B Cell Lymphoma | Phase 1 / Phase 2 | 2015-12-02 |